K. Habib

Oral administration of a corticotropin-releasing hormone receptor antagonist significantly attenuates behavioral, neuroendocrine, and autonomic responses to stress in primates.

G. Chrousos, J. Schulkin, M. Champoux, 2000, Proceedings of the National Academy of Sciences of the United States of America.

Neuroendocrinology of stress.

G. Chrousos, P. Gold, G P Chrousos, 2001, Endocrinology and metabolism clinics of North America.

Synthesis of doubly 13C-labelled antalarmin isotopomers for pharmacokinetic studies

N. Whittaker, G. Chrousos, C. Contoreggi, 2002 .

The development of a potential single photon emission computed tomography (SPECT) imaging agent for the corticotropin-releasing hormone receptor type.

G. Chrousos, C. Contoreggi, K. Rice, 2001, Bioorganic & medicinal chemistry letters.

CRHR1 Receptor binding and lipophilicity of pyrrolopyrimidines, potential nonpeptide corticotropin-releasing hormone type 1 receptor antagonists.

G. Chrousos, C. Contoreggi, K. Rice, 2002, Bioorganic & medicinal chemistry.